Research graph
References from Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms. Local targets link to admitted publications; unresolved targets remain external evidence.
Molecular profiling in MPN: who should have it and why?
10.1182/hematology.2024000576 · 2024 · External reference
Ocular manifestations in patients with philadelphia-negative myeloproliferative neoplasms
10.3390/cancers12030573 · 2020 · External reference
Ocular manifestations in hematological disorders
2022 · External reference
Augenveränderungen bei hämatologischen Erkrankungen [Ocular findings in hematological diseases]
10.1007/s00347-011-2430-x · 2011 · External reference
Ophthalmic manifestations in patients with blood malignancies
10.3390/hematolrep16020020 · 2024 · External reference
Ocular involvement in leukemia–a study of 288 cases
10.1159/000073077 · 2003 · External reference
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden
10.1182/blood-2008-03-143602 · 2008 · External reference
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
10.1182/blood-2015-06-652941 · 2016 · External reference
Characterization of myeloproliferative neoplasms in the pediatric and young adult population
10.1111/bjh.18650 · 2023 · External reference
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12
10.1111/bjh.14061 · 2016 · External reference
MIPSS70+ version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis
10.1200/jco.2018.78.9867 · 2018 · External reference
Adolescent and young adult oncology: an emerging field
10.1200/jco.2010.30.5128 · 2010 · External reference
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a position paper on behalf of the chronic malignancies working party of the EBMT
10.1016/s2352-3026(22)00330-1 · 2023 · External reference
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL
10.1182/blood.2023020232 · 2024 · External reference
The 5th edition of the world health organization classification of haematolymphoid tumors: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022 · External reference
Epidemiology of MPN: what do we know?
10.1007/s11899-014-0228-z · 2014 · External reference
Advances in molecular understanding of polycythemia vera, essential thrombocythemia, and primary myelofibrosis: towards precision medicine
10.3390/cancers16091679 · 2024 · External reference
Advances in myelodysplastic/myeloproliferative neoplasms
10.1007/s00428-022-03465-7 · 2023 · External reference
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
10.1186/s13045-017-0425-z · 2017 · External reference
Myeloproliferative neoplasms: contemporary review and molecular landscape
10.3390/ijms242417383 · 2023 · External reference
Somatic mutations of calreticulin in myeloproliferative neoplasms
10.1056/nejmoa1311347 · 2013 · External reference
Age-related macular degeneration in patients with chronic myeloproliferative neoplasms
10.1001/jamaophthalmol.2017.2011 · 2017 · External reference
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
10.1093/eurheartj/ehab447 · 2021 · External reference
Diagnosis and treatment of polycythemia vera: a review
10.1001/jama.2024.20377 · 2025 · External reference
Myeloproliferative neoplasms and cardiovascular disease: a review
10.1007/s11864-024-01255-8 · 2024 · External reference
Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates
10.1016/j.jaapos.2012.04.006 · 2012 · External reference
Bleeding complications in JAK2-variant essential thrombocythemia: a revisit in 2025
10.1002/jha2.70088 · 2025 · External reference
Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography
10.1111/bjh.12290 · 2013 · External reference
Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report
10.1186/s12886-022-02423-w · 2022 · External reference
High levels of C5a are associated with reduced macular sensitivity in patients with myeloproliferative neoplasms
10.1167/iovs.66.2.41 · 2025 · External reference
Diagnosis and treatment of polycythemia vera: a review
10.1001/jama.2024.20377 · ExternalCitation · doi-reference
Age-related macular degeneration in patients with chronic myeloproliferative neoplasms
10.1001/jamaophthalmol.2017.2011 · ExternalCitation · doi-reference
Bleeding complications in JAK2-variant essential thrombocythemia: a revisit in 2025
10.1002/jha2.70088 · ExternalCitation · doi-reference
Augenveränderungen bei hämatologischen Erkrankungen [Ocular findings in hematological diseases]
10.1007/s00347-011-2430-x · ExternalCitation · doi-reference
Advances in myelodysplastic/myeloproliferative neoplasms
10.1007/s00428-022-03465-7 · ExternalCitation · doi-reference
Myeloproliferative neoplasms and cardiovascular disease: a review
10.1007/s11864-024-01255-8 · ExternalCitation · doi-reference
Epidemiology of MPN: what do we know?
10.1007/s11899-014-0228-z · ExternalCitation · doi-reference
Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates
10.1016/j.jaapos.2012.04.006 · ExternalCitation · doi-reference
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a position paper on behalf of the chronic malignancies working party of the EBMT
10.1016/s2352-3026(22)00330-1 · ExternalCitation · doi-reference
The 5th edition of the world health organization classification of haematolymphoid tumors: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · ExternalCitation · doi-reference
Somatic mutations of calreticulin in myeloproliferative neoplasms
10.1056/nejmoa1311347 · ExternalCitation · doi-reference
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
10.1093/eurheartj/ehab447 · ExternalCitation · doi-reference
Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography
10.1111/bjh.12290 · ExternalCitation · doi-reference
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12
10.1111/bjh.14061 · ExternalCitation · doi-reference
Characterization of myeloproliferative neoplasms in the pediatric and young adult population
10.1111/bjh.18650 · ExternalCitation · doi-reference
Ocular involvement in leukemia–a study of 288 cases
10.1159/000073077 · ExternalCitation · doi-reference
High levels of C5a are associated with reduced macular sensitivity in patients with myeloproliferative neoplasms
10.1167/iovs.66.2.41 · ExternalCitation · doi-reference
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden
10.1182/blood-2008-03-143602 · ExternalCitation · doi-reference
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
10.1182/blood-2015-06-652941 · ExternalCitation · doi-reference
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL
10.1182/blood.2023020232 · ExternalCitation · doi-reference
Molecular profiling in MPN: who should have it and why?
10.1182/hematology.2024000576 · ExternalCitation · doi-reference
Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report
10.1186/s12886-022-02423-w · ExternalCitation · doi-reference
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
10.1186/s13045-017-0425-z · ExternalCitation · doi-reference
Adolescent and young adult oncology: an emerging field
10.1200/jco.2010.30.5128 · ExternalCitation · doi-reference
MIPSS70+ version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis
10.1200/jco.2018.78.9867 · ExternalCitation · doi-reference
Ocular manifestations in patients with philadelphia-negative myeloproliferative neoplasms
10.3390/cancers12030573 · ExternalCitation · doi-reference
Advances in molecular understanding of polycythemia vera, essential thrombocythemia, and primary myelofibrosis: towards precision medicine
10.3390/cancers16091679 · ExternalCitation · doi-reference
Ophthalmic manifestations in patients with blood malignancies
10.3390/hematolrep16020020 · ExternalCitation · doi-reference
Myeloproliferative neoplasms: contemporary review and molecular landscape
10.3390/ijms242417383 · ExternalCitation · doi-reference
